Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Cytomegalovirus Infection

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 44 articles: HTML format

Single Articles

March 2021
1. NASERI-NOSAR P, Nogalski MT, Shenk T
   The aryl hydrocarbon receptor facilitates the human cytomegalovirus-mediated G1/S block to cell cycle progression.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   
2. GROVES IJ, Jackson SE, Poole EL, Nachshon A, et al
   Bromodomain proteins regulate human cytomegalovirus latency and reactivation allowing epigenetic therapeutic intervention.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   December 2020
3. NOGALSKI MT, Shenk T
   HSATII RNA is induced via a noncanonical ATM-regulated DNA damage response pathway and promotes tumor cell proliferation and movement.
   Proc Natl Acad Sci U S A. 2020;117:31891-31901.
   PubMed     Abstract available
   
   
   September 2020
4. RAMANATHAN A, Weintraub M, Orlovetskie N, Serruya R, et al
   A mutation in POLR3E impairs antiviral immune response and RNA polymerase III.
   Proc Natl Acad Sci U S A. 2020;117:22113-22121.
   PubMed     Abstract available
   
   
   
5. HU Z, Tang A, Singh J, Bhattacharya S, et al
   A robust and interpretable end-to-end deep learning model for cytometry data.
   Proc Natl Acad Sci U S A. 2020;117:21373-21380.
   PubMed     Abstract available
   
   
   August 2020
6. KRISHNA BA, Wass AB, O'Connor CM
   Activator protein-1 transactivation of the major immediate early locus is a determinant of cytomegalovirus reactivation from latency.
   Proc Natl Acad Sci U S A. 2020 Aug 11. pii: 2009420117.
   PubMed     Abstract available
   
   
   
7. FULKERSON HL, Chesnokova LS, Kim JH, Mahmud J, et al
   HCMV-induced signaling through gB-EGFR engagement is required for viral trafficking and nuclear translocation in primary human monocytes.
   Proc Natl Acad Sci U S A. 2020;117:19507-19516.
   PubMed     Abstract available
   
   
   
8. 
   Correction for Chaudhry et al., Cytomegalovirus inhibition of extrinsic apoptosis determines fitness and resistance to cytotoxic CD8 T cells.
   Proc Natl Acad Sci U S A. 2020 Aug 3. pii: 2014825117.
   PubMed    
   
   
   
9. LANE RK, Guo H, Fisher AD, Diep J, et al
   Necroptosis-based CRISPR knockout screen reveals Neuropilin-1 as a critical host factor for early stages of murine cytomegalovirus infection.
   Proc Natl Acad Sci U S A. 2020 Aug 3. pii: 1921315117.
   PubMed     Abstract available
   
   
   July 2020
10. HALE AE, Collins-McMillen D, Lenarcic EM, Igarashi S, et al
    FOXO transcription factors activate alternative major immediate early promoters to induce human cytomegalovirus reactivation.
    Proc Natl Acad Sci U S A. 2020 Jul 21. pii: 2002651117.
    PubMed     Abstract available
    
    
    
11. CHATURVEDI S, Klein J, Vardi N, Bolovan-Fritts C, et al
    A molecular mechanism for probabilistic bet hedging and its role in viral latency.
    Proc Natl Acad Sci U S A. 2020;117:17240-17248.
    PubMed     Abstract available
    
    
    
12. FLETCHER-ETHERINGTON A, Nobre L, Nightingale K, Antrobus R, et al
    Human cytomegalovirus protein pUL36: A dual cell death pathway inhibitor.
    Proc Natl Acad Sci U S A. 2020 Jul 20. pii: 2001887117.
    PubMed     Abstract available
    
    
    May 2020
13. CHAUDHRY MZ, Casalegno-Garduno R, Sitnik KM, Kasmapour B, et al
    Cytomegalovirus inhibition of extrinsic apoptosis determines fitness and resistance to cytotoxic CD8 T cells.
    Proc Natl Acad Sci U S A. 2020 May 22. pii: 1914667117.
    PubMed     Abstract available
    
    
    January 2020
14. HOULDCROFT CJ, Cudini J, Goldstein RA, Breuer J, et al
    Reply to Jensen and Kowalik: Consideration of mixed infections is central to understanding HCMV intrahost diversity.
    Proc Natl Acad Sci U S A. 2020;117:818-819.
    PubMed    
    
    
    December 2019
15. JENSEN JD, Kowalik TF
    A consideration of within-host human cytomegalovirus genetic variation.
    Proc Natl Acad Sci U S A. 2019 Dec 24. pii: 1915295117.
    PubMed    
    
    
    
16. GAMACHE A, Cronk JM, Nash WT, Puchalski P, et al
    Ly49R activation receptor drives self-MHC-educated NK cell immunity against cytomegalovirus infection.
    Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 1913064117.
    PubMed     Abstract available
    
    
    September 2019
17. CHEN S, Shenk T, Nogalski MT
    P2Y2 purinergic receptor modulates virus yield, calcium homeostasis, and cell motility in human cytomegalovirus-infected cells.
    Proc Natl Acad Sci U S A. 2019 Sep 3. pii: 1907562116.
    PubMed     Abstract available
    
    
    August 2019
18. SONG J, Lee S, Cho DY, Lee S, et al
    Human cytomegalovirus induces and exploits Roquin to counteract the IRF1-mediated antiviral state.
    Proc Natl Acad Sci U S A. 2019 Aug 26. pii: 1909314116.
    PubMed     Abstract available
    
    
    
19. TANG J, Frascaroli G, Lebbink RJ, Ostermann E, et al
    Human cytomegalovirus glycoprotein B variants affect viral entry, cell fusion, and genome stability.
    Proc Natl Acad Sci U S A. 2019 Aug 19. pii: 1907447116.
    PubMed     Abstract available
    
    
    
20. COLLINS-MCMILLEN D, Rak M, Buehler JC, Igarashi-Hayes S, et al
    Alternative promoters drive human cytomegalovirus reactivation from latency.
    Proc Natl Acad Sci U S A. 2019 Aug 13. pii: 1900783116.
    PubMed     Abstract available
    
    
    July 2019
21. FENG Y, Daley-Bauer LP, Roback L, Guo H, et al
    Caspase-8 restricts antiviral CD8 T cell hyperaccumulation.
    Proc Natl Acad Sci U S A. 2019;116:15170-15177.
    PubMed     Abstract available
    
    
    June 2019
22. DEERE JD, Chang WLW, Villalobos A, Schmidt KA, et al
    Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity.
    Proc Natl Acad Sci U S A. 2019 Jun 12. pii: 1903317116.
    PubMed     Abstract available
    
    
    March 2019
23. E X, Meraner P, Lu P, Perreira JM, et al
    OR14I1 is a receptor for the human cytomegalovirus pentameric complex and defines viral epithelial cell tropism.
    Proc Natl Acad Sci U S A. 2019 Mar 20. pii: 1814850116.
    PubMed     Abstract available
    
    
    February 2019
24. CUDINI J, Roy S, Houldcroft CJ, Bryant JM, et al
    Human cytomegalovirus haplotype reconstruction reveals high diversity due to superinfection and evidence of within-host recombination.
    Proc Natl Acad Sci U S A. 2019 Feb 28. pii: 1818130116.
    PubMed     Abstract available
    
    
    
25. VANARSDALL AL, Chin AL, Liu J, Jardetzky TS, et al
    HCMV trimer- and pentamer-specific antibodies synergize for virus neutralization but do not correlate with congenital transmission.
    Proc Natl Acad Sci U S A. 2019;116:3728-3733.
    PubMed     Abstract available
    
    
    January 2019
26. KRISHNA BA, Humby MS, Miller WE, O'Connor CM, et al
    Human cytomegalovirus G protein-coupled receptor US28 promotes latency by attenuating c-fos.
    Proc Natl Acad Sci U S A. 2019 Jan 15. pii: 1816933116.
    PubMed     Abstract available
    
    
    December 2018
27. LUGANINI A, Di Nardo G, Munaron L, Gilardi G, et al
    Human cytomegalovirus US21 protein is a viroporin that modulates calcium homeostasis and protects cells against apoptosis.
    Proc Natl Acad Sci U S A. 2018 Dec 10. pii: 1813183115.
    PubMed     Abstract available
    
    
    October 2018
28. WU K, Oberstein A, Wang W, Shenk T, et al
    Role of PDGF receptor-alpha during human cytomegalovirus entry into fibroblasts.
    Proc Natl Acad Sci U S A. 2018 Oct 1. pii: 1806305115.
    PubMed     Abstract available
    
    
    September 2018
29. VARDI N, Chaturvedi S, Weinberger LS
    Feedback-mediated signal conversion promotes viral fitness.
    Proc Natl Acad Sci U S A. 2018;115:E8803-E8810.
    PubMed     Abstract available
    
    
    July 2018
30. SMITHEY MJ, Venturi V, Davenport MP, Buntzman AS, et al
    Lifelong CMV infection improves immune defense in old mice by broadening the mobilized TCR repertoire against third-party infection.
    Proc Natl Acad Sci U S A. 2018 Jul 2. pii: 1719451115.
    PubMed     Abstract available
    
    
    June 2018
31. SCHLEISS MR
    Recombinant cytomegalovirus glycoprotein B vaccine: Rethinking the immunological basis of protection.
    Proc Natl Acad Sci U S A. 2018 Jun 6. pii: 1806420115.
    PubMed    
    
    
    April 2018
32. NELSON CS, Huffman T, Jenks JA, Cisneros de la Rosa E, et al
    HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions.
    Proc Natl Acad Sci U S A. 2018 Apr 30. pii: 1800177115.
    PubMed     Abstract available
    
    
    
33. WANG ECY, Pjechova M, Nightingale K, Vlahava VM, et al
    Suppression of costimulation by human cytomegalovirus promotes evasion of cellular immune defenses.
    Proc Natl Acad Sci U S A. 2018 Apr 24. pii: 1720950115.
    PubMed     Abstract available
    
    
    
34. BARANIAK I, Kropff B, Ambrose L, McIntosh M, et al
    Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies.
    Proc Natl Acad Sci U S A. 2018 Apr 23. pii: 1800224115.
    PubMed     Abstract available
    
    
    January 2018
35. MOLLER R, Schwarz TM, Noriega VM, Panis M, et al
    miRNA-mediated targeting of human cytomegalovirus reveals biological host and viral targets of IE2.
    Proc Natl Acad Sci U S A. 2018 Jan 16. pii: 1719036115.
    PubMed     Abstract available
    
    
    
36. VAN DER ZWAN A, Bi K, Norwitz ER, Crespo AC, et al
    Mixed signature of activation and dysfunction allows human decidual CD8(+) T cells to provide both tolerance and immunity.
    Proc Natl Acad Sci U S A. 2018;115:385-390.
    PubMed     Abstract available
    
    
    November 2017
37. CHENG S, Caviness K, Buehler J, Smithey M, et al
    Transcriptome-wide characterization of human cytomegalovirus in natural infection and experimental latency.
    Proc Natl Acad Sci U S A. 2017 Nov 20. pii: 201710522.
    PubMed     Abstract available
    
    
    September 2017
38. OBERSTEIN A, Shenk T
    Cellular responses to human cytomegalovirus infection: Induction of a mesenchymal-to-epithelial transition (MET) phenotype.
    Proc Natl Acad Sci U S A. 2017 Sep 5. pii: 201710799.
    PubMed     Abstract available
    
    
    May 2017
39. MURRELL I, Bedford C, Ladell K, Miners KL, et al
    The pentameric complex drives immunologically covert cell-cell transmission of wild-type human cytomegalovirus.
    Proc Natl Acad Sci U S A. 2017 May 22. pii: 201704809.
    PubMed     Abstract available
    
    
    March 2017
40. DALEY-BAUER LP, Roback L, Crosby LN, McCormick AL, et al
    Mouse cytomegalovirus M36 and M45 death suppressors cooperate to prevent inflammation resulting from antiviral programmed cell death pathways.
    Proc Natl Acad Sci U S A. 2017 Mar 14. pii: 201616829.
    PubMed     Abstract available
    
    
    February 2017
41. VYSOCHAN A, Sengupta A, Weljie AM, Alwine JC, et al
    ACSS2-mediated acetyl-CoA synthesis from acetate is necessary for human cytomegalovirus infection.
    Proc Natl Acad Sci U S A. 2017 Feb 6. pii: 201614268.
    PubMed     Abstract available
    
    
    January 2017
42. JENSEN H, Chen SY, Folkersen L, Nolan GP, et al
    EBI3 regulates the NK cell response to mouse cytomegalovirus infection.
    Proc Natl Acad Sci U S A. 2017 Jan 31. pii: 201700231.
    PubMed     Abstract available
    
    
    November 2016
43. FAN YH, Roy S, Mukhopadhyay R, Kapoor A, et al
    Role of nucleotide-binding oligomerization domain 1 (NOD1) and its variants in human cytomegalovirus control in vitro and in vivo.
    Proc Natl Acad Sci U S A. 2016 Nov 16. pii: 201611711.
    PubMed     Abstract available
    
    
    June 2016
44. DICK JE, Hilterbrand AT, Strawsine LM, Upton JW, et al
    Enzymatically enhanced collisions on ultramicroelectrodes for specific and rapid detection of individual viruses.
    Proc Natl Acad Sci U S A. 2016;113:6403-8.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: